Dowsany retweeted
GenSight Biologics Announces Positive Data Safety Monitoring Board Review of PIONEER Phase I/II Clinical Trial of GS030 as Optogenetic Treatment for Retinitis Pigmentosa | Business Wire businesswire.com/news/home/2…
Dowsany retweeted
Study: Some RP abnormalities are linked with lower visual acuity #ophthalmology #retina buff.ly/3of9Rlm
Dowsany retweeted
What's the latest in using #stemcells in #stroke recovery? Can stem cell therapy help reverse vision loss? All the answers to all your questions https://xitter.gq/t.co/Yk5Qx4kWwd @CIRMnews @US_FDA @UCLAstemcell @UCSF @UCSDHealth @cityofhope @AsteriasBio
Dowsany retweeted
.@ProQR has announced that the first patient in its Aurora Phase 1/2 #clinicaltrial has received QR-1123, the company’s emerging therapy for autosomal dominant retinitis pigmentosa caused by RHO-P23H mutation. fightingblindness.org/resear…
Dowsany retweeted
GenSight Biologics reports findings from REALITY study and REVERSE-RESCUE analysis highlighting positive benefits from LUMEVOQ™ (GS010) compared to LHON natural history | Business Wire businesswire.com/news/home/2…
#LHON #rarediseases #blindness #neurodegeneration #biotech
Dowsany retweeted
ViGeneron to develop next-gen eye gene therapies after funding round pharmaphorum.com/?p=61852 vía @pharmaphorum
Dowsany retweeted
Novel dual-vector delivery system for Stargardt disease gene therapy
ow.ly/828x50xpqo4
#Stargardt #genetherapy
Dowsany retweeted
AGTC Announces Departure of Chief Medical Officer, Company on Track to Announce XLRP and ACHM Dat... finance.yahoo.com/news/agtc-… vía @YahooFinance
Dowsany retweeted
Dr Ray Wong is investigating cell reprogramming technology that could regenerate photoreceptors in the eye – offering hope for a potential treatment for #RetinitisPigmentosa. @nhmrc cera.org.au/2019/12/could-lo… #Vision
Dowsany retweeted
Kobe Hospital Planning iPS Treatment of Retinal Disease nippon.com/en/news/yjj201912…
Dowsany retweeted
Researchers from @uni_tue, a @BCNMaculaFoundE partner, together with @FraunhoferIGB’s researchers haver engineered a highly developed model of the human retina that could revolutionize the development of the treatment for #retina’s diseases 👉 https://xitter.gq/t.co/am9KV2r0uU
Dowsany retweeted
AAV8-RGPR Demonstrates Safety, Efficacy in X-Linked Retinitis Pigmentosa mdmag.com/conference-coverag… vía @mdmagazine
Dowsany retweeted
ReNeuron shares clinical data on stem cell vision loss therapy fiercebiotech.com/biotech/re…
Dowsany retweeted
Gene Therapy in Retinal Diseases docwirenews.com/latest-ophth… vía @mydocwire
Dowsany retweeted
AGTC Presents Data Demonstrating Efficiency of its AAV Vectors for Ocular Gene Therapy Even in the Presence of Anti-AAV Antibodies - EIN News einnews.com/pr_news/49986698… vía @ein_news
Dowsany retweeted
Multidisciplinary team to develop stem cell-based approaches to restore vision penntoday.upenn.edu/news/mul…
Dowsany retweeted
Spark Therapeutics Launches New Initiative to Raise Awareness of the Importance of Genetic Testing for People Living with Inherited Retinal Diseases - EIN News einnews.com/pr_news/46618780… vía @ein_news
Dowsany retweeted
Researchers create a better artificial retina: news-medical.net/news/201808…
Dowsany retweeted
The science behind #bluelight and #photoreceptor damage in the #retina that can cause #visionloss. #maculardegeneration
https://xitter.gq/t.co/Z5LzrqB271
Dowsany retweeted
This mobility device for obstacle warning does not use ultrasound but radar technology. Interesting indeed! #AssistiveTechnology #LowVision #blind
Guidesense | A wearable assistive device for the visually impaired guidesense.com/en/ #guidesense #opastutka














